KRT14 and cervical cancer: Consistent with previous reports (Riley et al., 2003), KRT14-E6 and KRT-E7 mice rarely developed cervical cancer without exposure to a relatively high concentration of estrogen, even after treatment with a low concentration of Dox for 1.5 years.